SARS-CoV-2 protein Nsp1 alters actomyosin cytoskeleton and phenocopies arrhythmogenic cardiomyopathy-related PKP2 mutant
Authors:
- Andrés González-GuerraAGAndrés González-Guerra
- Emilio CamafeitaECEmilio Camafeita
- Daniel Martín-PérezDMDaniel Martín-Pérez
- Cristina Sánchez-RamosCSCristina Sánchez-Ramos
Preprint
Abstract
Mutations in desmosomal Plakophilin-2 (PKP2) are the most prevalent drivers of arrhythmogenic cardiomyopathy (ACM) and a common cause of sudden cardiac death in young athletes. However, partner proteins that elucidate PKP2 cellular mechanism to understand cardiac dysfunction in ACM are mostly unknown. Here we identify the actin-based motor proteins Myh9 and Myh10 as key PKP2 interactors, and demonstrate that the expression of the ACM-related PKP2 mutant R735X alters actin fiber organization and cell mechanical stiffness. We also show that SARS-CoV-2 Nsp1 protein acts similarly to this known pathogenic R735X mutant, altering the actomyosin component distribution on cardiac cells. Our data reveal that the viral Nsp1 hijacks PKP2 into the cytoplasm and mimics the effect of delocalized R735X mutant. These results demonstrate that cytoplasmic PKP2, wildtype or mutant, induces the collapse of the actomyosin network, since shRNA- PKP2 knockdown maintains the cell structure, validating a critical role of PKP2 localization in the regulation of actomyosin architecture. The fact that Nsp1 and PKP2 mutant R735X share similar phenotypes also suggests that direct SARS-CoV-2 heart infection could induce a transient ACM-like disease in COVID-19 patients, which may contribute to right ventricle dysfunction, observed in patients with poor survival prognosis. Highlights: The specific cardiac isoform Plakophilin-2a (PKP2) interacts with Myh9 and Myh10. PKP2 delocalization alters actomyosin cytoskeleton component organization. SARS-CoV-2 Nsp1 protein hijacks PKP2 from the desmosome into the soluble fraction where it is downregulated. Viral Nsp1 collapses the actomyosin cytoskeleton and phenocopies the arrhythmogenic cardiomyopathy-related mutant R735X.Keywords
This publication has 50 references indexed in Scilit:
- Right Ventricular Dilation in Hospitalized Patients With COVID-19 InfectionJACC: Cardiovascular Imaging, 2020
- Molecular mechanisms of arrhythmogenic cardiomyopathyNature Reviews Cardiology, 2019
- Athletic Training and Arrhythmogenic Right Ventricular CardiomyopathyInternational Journal of Sports Medicine, 2019
- Arrhythmogenic CardiomyopathyCirculation Research, 2017
- Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriersEuropean Heart Journal, 2015
- Stop-Gain Mutations in PKP2 Are Associated with a Later Age of Onset of Arrhythmogenic Right Ventricular CardiomyopathyPLOS ONE, 2014
- Mechanistic Basis of Desmosome-Targeted DiseasesJournal of Molecular Biology, 2013
- A Robust Method for Quantitative High-throughput Analysis of Proteomes by 18O LabelingMolecular & Cellular Proteomics, 2011
- Generation of an inducible and optimized piggyBac transposon system†Nucleic Acids Research, 2007
- HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyteProceedings of the National Academy of Sciences, 1998